Communiqués de presse U.S. FDA Santé & sciences de la vie — Flux RSS et veille en direct
PPN World suit le flux RSS de U.S. FDA en temps réel — 14 communiqués indexés au cours des 30 derniers jours, le plus récent est arrivé il y a 2 j. Suivez-le avec alertes sur recherches enregistrées, résumés IA et recherche plein texte, ou branchez l'URL RSS ci-dessous dans votre propre lecteur.
À propos de ce fil
U.S. FDA fait partie des 1,200+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « États-Unis » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. Au cours des 30 derniers jours, U.S. FDA a publié 14 communiqués, surtout le jeudi, avec une couverture récente centrée sur fda-approval, drug, screwworm.
Suivez U.S. FDA en temps réel dans PPN World
Chaque communiqué de U.S. FDA arrive dans le cockpit quelques secondes après sa publication — dédupliqué, classé, avec alertes sur recherches enregistrées et résumés IA, aux côtés de 1,200+ autres fils. Essai gratuit de 7 jours, sans carte.
Commencer l'essai gratuit →Derniers communiqués de U.S. FDA
- FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Productsil y a 2 j
The U.S. Food and Drug Administration today announced it is taking action, consistent with the Trump administration’s commitment to protecting vulnerable patients and maintaining access to critical me…
- FDA Grants Accelerated Approval to a New Breast Cancer Treatmentil y a 2 j
The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new t…
- FDA Approves First Drug to Treat Alexander Diseaseil y a 3 j
The U.S. Food and Drug Administration has approved Zanvastro (zilganersen) injection for the treatment of Alexander disease in pediatric and adult patients.
- FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Catsil y a 3 j
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, the generic version of Capstar
- FDA Seeks Public Input to Advance Development of Botanical Drug Productsil y a 3 j
The U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
- FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorderil y a 8 j
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cell…
- FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adultsil y a 10 j
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
- FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattleil y a 10 j
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of b…
- FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Canceril y a 11 j
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced…
- FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugaril y a 12 j
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Iail y a 17 j
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older…
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Deviceil y a 18 j
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention.
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.